Abstract
Cardiac arrhythmias occurring during the intraoperative period for cardiac surgery have been associated with excess morbidity and mortality. Several antiarrhythmics have been utilized for the management of intraoperative arrhythmias. These antiarrhythmic medications can cause undesirable adverse outcomes in the intensive care setting. The incidence and treatment of adult intraoperative arrhythmias have been studied. In addition, the prevalence, risk factors, and optimal treatment of pediatric postoperative arrhythmias have also been studied. However, the literature has not been published on intraoperative antiarrhythmia treatment during pediatric cardiac surgery. The purpose of this study was to determine the safety of intraoperative antiarrhythmic medications utilized in pediatric cardiac surgery patients. This was a retrospective review of all patients who received an intraoperative antiarrhythmic in the cardiovascular operating room at Texas Children’s Hospital. Patients were included if they underwent cardiovascular surgery from November 2008 to July 2013 and were excluded if antiarrhythmics were given intraoperatively for other indications (i.e., esmolol for hypertension) or if patients were older than 18 years of age. Safety of antiarrhythmic treatment was determined by the absence or presence of adverse events. Control or recurrence of the arrhythmia was analyzed as a secondary measure to help determine antiarrhythmic efficacy. A total of 45 patients were identified (53.3 % male). Patients were a median of 0.52 years at the time of surgery. Primary surgery types were tetralogy of Fallot repair (n = 6; 13.3 %) and ventricular septal defect closure (n = 5, 11.1 %). Thirty-one patients (68.9 %) had documented adverse events after the administration of antiarrhythmics. Most of these adverse events occurred after the administration of amiodarone (n = 16; 51.6 %) followed by esmolol (n = 15; 48.4 %). Fifty-one percent of the arrhythmias resolved in the operating room (n = 23), and nearly half (n = 19) of all patients were discharged home on an antiarrhythmic medication. A high incidence of adverse events was associated with intraoperative administration of antiarrhythmic medications.
Similar content being viewed by others
References
Atlee J (1997) Perioperative cardiac dysrhythmias: diagnosis and management. Anesthesiology 86(6):1397–1424
Bouhouch R, El Houri T, Fellar I, Arharbi M (2008) Pharmacological therapy in children with nodal reentry tachycardia: when, how and how long to treat the affected patients. Curr Pharm Des 14:766–769
Chang P et al (2010) Amiodarone versus procainamide for the acute treatment of recurrent supraventricular tachycardia in pediatric patients. Circ Arrhythm Electrophysiol 3:134–140
Cohen Y, Sijka M (2012) Management of postoperative arrhythmias in pediatric patients. Curr Treat Options Cardiovasc Med 14:443–454
Delaney J, Moltedo J, Dziura J, Kopf G, Snyder S (2006) Early postoperative arrhythmias after pediatric cardiac surgery. J Thorac Cardiovasc Surg 131:1296–1301
Escudero C, Carr R, Sanatani S (2013) Overview of antiarrhythmic drug therapy for supraventricular tachycardia in children. Prog Pediatr Cardiol 35:55–63
Fengler B, Brady W, Plautz C (2007) Atrial fibrillation in the Wolff–Parkinson–White syndrome: ECG recognition and treatment in the ED. Am J Emerg Med 25:576–583
Figa F, Gow R, Hamilton R, Freedom R (1994) Clinical efficacy and safety of intravenous amiodarone in infants and children. Am J Cardiol 74:573–577
Grosse-Wortmann L, Kreitz S, Grabitz R et al (2010) Prevalence of and risk factors for perioperative arrhythmias in neonates and children after cardiopulmonary bypass: continuous holter monitoring before and for three days after surgery. J Cardiothor Surg 5:85
Kuner L, Enescu V, Utsu F, Boszormenyi E, Bernstein H, Corday E (1967) Cardiac arrhythmias during anesthesia. Chest 52(5):580–587
Leudtke S, Kuhn R, McCaffrey F (1997) Pharmacologic management of supraventricular tachycardia in children. Part 2: atrial flutter, atrial fibrillation, and junctional and atrial tachycardia. Ann Pharmacother 31:1347–1359
McComb J (1993) Safety of antiarrhythmic drugs in children. Br Heart J 70(1):13–14
Moffett B, Maciek S (2013) Pediatric pharmacotherapy. ACCP, Lenexa, pp 129–144
Paul T, Guccione P (1994) New antiarrhythmic drugs in pediatric use: amiodarone. Pedaitr Cardiol 15(3):132–138
Rolf N, Cote C (1991) Persistent cardiac arrhythmias in pediatric patients: effects of age, expired carbon dioxide values, depth of anesthesia, and airway management. Pediatr Anesth 73:720–724
Saul J et al (2005) Intravenous amiodarone for incessant tachyarrhythmias in children: a randomized, double-blind, antiarrhythmic drug trial. Circulation 112:3470–3477
Thompson A, Balser R (2004) Perioperative cardiac arrhythmias. Br J Anesth 93(1):86–94
Trippel A, Wiest D, Gillette P (1991) Cardiovascular and antiarrhythmic effects of esmolol in children. J Pediatr 119(1):142–148
Trippel D, Weist D, Gillette P (1991) Cardiovascular and antiarrhythmic effects of esmolol in children. J Pediatr 119:142–147
Waldo AL, Henthorn RW, Epstein AE, Plumb VJ (1984) Diagnosis and treatment of arrhythmias during and following open heart surgery. Med Clin North Am 68:1153–1170
Conflict of interest
None to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Beaty, R.S., Moffett, B.S., Hall, S. et al. Evaluating the Safety of Intraoperative Antiarrhythmics in Pediatric Cardiac Surgery Patients. Pediatr Cardiol 36, 1465–1469 (2015). https://doi.org/10.1007/s00246-015-1187-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-015-1187-4